Lipella Pharmaceuticals Inc. (LIPO) Net margin 2021–2024
Lipella Pharmaceuticals Inc. (LIPO) net profit margin by fiscal year — reported net income divided by reported revenue.
-935.2%FY2024 · since FY2021: -719.3% → -935.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -935.2% | +92.1 pp |
| FY2023 | -1027.3% | +383.3 pp |
| FY2022 | -1410.6% | -691.3 pp |
| FY2021 | -719.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More LIPO financial trends
LIPO RevenueLIPO Net incomeLIPO Gross profitLIPO Gross marginLIPO Operating incomeLIPO Operating marginLIPO Operating cash flowLIPO Free cash flowLIPO Capital expendituresLIPO Return on equityLIPO Stock buybacksLIPO Dividends paidLIPO Total assetsLIPO Total liabilitiesLIPO Shareholders’ equityLIPO overview →